ENZULAMIDE 160 is a targeted oral anticancer medication containing Enzalutamide 160 mg, widely used in the treatment of advanced and castration-resistant prostate cancer. Prostate cancer is one of the most commonly diagnosed cancers among men, particularly in older age groups. In many patients, the disease progresses even after standard hormonal therapy, requiring advanced treatment options that act directly on cancer-promoting pathways.
ENZULAMIDE 160 belongs to a class of medicines known as androgen receptor inhibitors. It works by blocking the effect of androgens (male hormones like testosterone) that stimulate the growth of prostate cancer cells. By interrupting this hormonal signaling, ENZULAMIDE 160 helps slow disease progression, control symptoms, and improve overall survival outcomes when used under specialist supervision.
Uses
ENZULAMIDE 160 is primarily prescribed for the management of:
Metastatic castration-resistant prostate cancer (mCRPC)
Non-metastatic castration-resistant prostate cancer (nmCRPC)
Advanced prostate cancer that has progressed despite androgen deprivation therapy (ADT)
Prostate cancer requiring long-term androgen receptor blockade
It is commonly used in patients who no longer respond adequately to conventional hormonal treatments and is often given along with ongoing medical or surgical castration as advised by an oncologist.
Benefits
ENZULAMIDE 160 offers multiple clinically proven benefits in prostate cancer management:
Blocks androgen receptor signaling: Prevents male hormones from binding to cancer cells, thereby inhibiting tumor growth.
Slows disease progression: Helps delay cancer spread to bones and other organs.
Improves progression-free survival: Reduces the risk of disease worsening over time.
Controls cancer-related symptoms: Helps relieve pain, urinary symptoms, and cancer-associated discomfort.
Oral administration: Convenient tablet form allows home-based treatment without frequent hospital visits.
Supports long-term disease control: Suitable for extended therapy under medical supervision.
Improves quality of life: Enables patients to maintain better daily functioning during treatment.
These benefits make ENZULAMIDE 160 an important therapy in modern prostate cancer care.
Dosage
The dosage of ENZULAMIDE 160 should be followed strictly as prescribed by a qualified oncologist.
The usual recommended dose is 160 mg once daily.
Tablets should be swallowed whole with water.
Can be taken with or without food.
It is generally continued as long as clinical benefit is observed and side effects remain manageable.
Patients should not alter the dose, skip doses, or stop treatment without consulting their doctor, as this may affect treatment outcomes.
Side Effects
Like all anticancer medicines, ENZULAMIDE 160 may cause side effects, though not every patient experiences them. Commonly reported side effects include:
Fatigue or weakness
Hot flashes
Headache
Dizziness
High blood pressure
Reduced appetite
Joint or muscle pain
Less common but serious side effects may include:
Seizures
Cardiovascular complications
Severe weakness or confusion
Patients should immediately seek medical attention if they experience unusual neurological symptoms, severe dizziness, or sudden changes in health.
Precautions and Warning
ENZULAMIDE 160 should be used only under specialist medical supervision.
Not recommended for women or children.
Caution is required in patients with a history of seizures, brain injury, or neurological disorders.
Blood pressure and overall health should be monitored regularly during treatment.
Inform the doctor about all ongoing medications, including supplements and herbal products, to avoid drug interactions.
Alcohol consumption should be limited.
Patients experiencing dizziness or fatigue should avoid driving or operating heavy machinery.
Strict adherence to medical advice ensures safer and more effective treatment outcomes.
Conclusion
ENZULAMIDE 160 is a highly effective androgen receptor inhibitor that plays a critical role in the treatment of advanced and castration-resistant prostate cancer. By targeting the hormonal pathways responsible for cancer growth, it helps slow disease progression, manage symptoms, and improve survival outcomes.
When used as part of a comprehensive cancer treatment plan and under expert medical guidance, ENZULAMIDE 160 provides patients with improved disease control and a better quality of life. It stands as a reliable and advanced therapeutic option in modern prostate cancer management.
